Force Calibration and Dose Accuracy in Injection Pens: A Comprehensive Technical Guide
Introduction
Each year, more than 16 billion needle-based injections are administered globally, making injection pens one of the most frequently used medical devices in the world. For patients managing chronic conditions such as diabetes, autoimmune disorders, and hormonal deficiencies, the accuracy of each dose is not merely a matter of convenience—it is a matter of clinical efficacy and patient safety. A dose that deviates even slightly from the prescribed amount can lead to suboptimal therapeutic outcomes, hypoglycemic or hyperglycemic episodes, or treatment failure.
The global self-injection device market, valued at USD 4.88 billion in 2025, is projected to reach USD 15.11 billion by 2034, growing at a CAGR of 13.42%. Pen injectors alone are expected to account for 67.10% of this market by 2026. As the market expands and devices become more sophisticated—incorporating electronics, connectivity, and advanced materials—the engineering challenges of ensuring dose accuracy through precise force calibration become increasingly complex.
This comprehensive technical guide examines the critical relationship between force calibration and dose accuracy in injection pens, exploring the mechanical principles, regulatory requirements, testing methodologies, and material considerations that underpin reliable drug delivery.
At Vialab Pharmaceutical Packaging Co., Ltd. , we specialize in the design and manufacture of high-quality drug delivery and packaging components. From injection pens (disposable and reusable) to glass vials, sterile vials, and aluminum caps, every product is engineered to meet strict pharmaceutical standards. With advanced production lines and cleanroom facilities, we ensure consistent quality, integrity, and compliance for global healthcare partners.
1. The Critical Importance of Dose Accuracy
1.1 Clinical Consequences of Inaccurate Dosing
Dose accuracy in injection pens directly impacts patient outcomes. For insulin-dependent patients, a dose error of just a few units can cause dangerous blood glucose fluctuations. For biologic therapies with narrow therapeutic windows, inaccurate dosing can render treatment ineffective or cause adverse reactions.
Compared with vial and syringe administration, pen injectors offer greater accuracy and precision of dosing; less pain; and improved ease of use, flexibility, and convenience, thus enhancing user trust and adherence. However, this accuracy advantage is only realized when the pen’s mechanical systems are properly calibrated and maintained.
1.2 Dose Accuracy as a “Primary Function”
Under ISO 11608-1:2022, dose accuracy is designated as a primary function for all needle-based injection systems (NISs), including pen injectors and on-body delivery systems. A primary function is defined as a function or operation of the NIS which, if it does not perform to specifications during use, would directly result in a failure to accurately deliver the medicinal product via the correct route and/or directly result in unacceptable harm to the patient.
This designation carries significant regulatory weight. When it comes to verification of requirements identified as primary functions, the same approach and assessment criteria set out for dose accuracy must be applied. Risk management tools, per ISO 14971, must be applied to these primary functions.
1.3 Regulatory Framework for Dose Accuracy
ISO 11608-1:2022 specifies the requirements and test methods for NISs for single-patient use intended to deliver discrete volumes (bolus) of medicinal product. The standard applies to NISs incorporating pre-filled or user-filled, replaceable or non-replaceable containers.
The FDA treats pen injectors and drugs as combination products, requiring complete validation data on safety and effectiveness. The FDA’s guidance on pen, jet, and related injectors describes the technical and scientific information expected in marketing applications. FDA guidance further mandates that dose accuracy be maintained in accordance with ISO 11608-1 under operating conditions of 23°C ± 5°C / 50% ± 25% relative humidity.
USP Chapter <382> and USP Chapter <1382> reference ISO 11608-3, describing requirements for functional proficiency tests including breakaway force, glide force, and leak tightness. These requirements are particularly relevant for multi-dose pens that must maintain consistent performance across hundreds or thousands of injections.
2. The Mechanical Foundations of Dose Accuracy
2.1 The Force-Dose Relationship
At its core, dose accuracy in a pen injector depends on the precise translation of mechanical force into volumetric drug delivery. The fundamental relationship can be expressed as:
Dose Volume = Plunger Stroke × Cartridge Cross-Sectional Area
Any variation in the force applied to the plunger—or any mechanical inefficiency in transmitting that force—can alter the plunger stroke and, consequently, the delivered dose.
The primary forces involved in injection are the driving forces, the hydrodynamic forces, and the friction forces. The driving force, which powers the injection, varies depending on the mechanism—such as a spring in spring-driven devices or compressed gas in gas-driven systems. Hydrodynamic forces arise from the resistance of the drug fluid as it flows through the needle. Friction forces occur at multiple interfaces: between the plunger and cartridge wall, between moving mechanical components, and between the needle and tissue.
2.2 Force Calibration: The Key to Consistency
Force calibration is the process of ensuring that the forces generated by the pen’s mechanical systems—whether from spring compression, user thumb pressure, or electromechanical actuators—are consistent, predictable, and within specified tolerances.
Properly calibrated forces ensure patient comfort and ease of use. If the breakaway force is too high, it can cause pain, irritation, or bruising at the injection site. If the glide force is inconsistent, the delivered dose may vary from one injection to the next.
2.3 Sources of Force Variability
Spring Performance
Springs are the heart of most injection pen mechanisms. Whether torsion springs for dose setting or compression springs for drug delivery, spring performance directly impacts dose delivery accuracy. Key factors include:
- Spring stiffness (k): Determines the force generated for a given displacement
- Spring fatigue: Loss of force over repeated cycles
- Manufacturing variability: Inconsistent spring characteristics from different suppliers
- Environmental effects: Temperature-induced changes in spring properties
The predictable, linear spring rate means the injector delivers the intended force for needle insertion and drug delivery every time, improving dose accuracy and reliability. Profiled-load springs, engineered through simulation, can deliver nearly constant force over the entire stroke by adjusting coil pitch, diameter, material properties, and specific heat treatments.
Friction and Tribology
Friction is a major source of dose inaccuracy in injection pens. Sliding interfaces between polymer components require stable friction characteristics; uncontrolled changes can affect dose delivery or user actuation force.
Research has shown that material combinations used without lubrication generally have unsatisfactory performance, while silicone-based internal lubricating additives significantly improve performance. Tribologically modified grades offer improved sliding properties in terms of exceptional low friction and low wear properties.
Inconsistent lubrication leads to unstable injection force. Uneven silicone oil application and lack of process control are root causes that manufacturers must address through rigorous quality control.
Dimensional Tolerances
Tolerance stack-up—the cumulative effect of dimensional variations across multiple components—can jeopardize dose accuracy through mechanical instabilities due to loose connections between interrelated parts.
Materials such as POM (polyoxymethylene) or PBT (polybutylene terephthalate) are preferred for consistent actuation and torque control due to their excellent dimensional stability and creep resistance. These materials maintain dimensions under stress and across the device’s claimed lifetime to preserve dose accuracy.
2.4 Cartridge and Plunger Dynamics
The interaction between the cartridge and plunger is a critical determinant of dose accuracy. The elastomeric closure (plunger) is required to move in order to empty the container upon demand. The Break Force, Glide Force, and Plunger Seal Integrity tests are provided in USP <382> to aid the evaluation of these systems.
Break-loose force is the force required to initiate movement of the plunger. Glide force (or sustaining force) is the force required to maintain movement. Both must be controlled within specified limits to ensure consistent dosing.
In pre-filled syringes, cartridges, and pens, the power spring directly presses on the plunger stopper, and the force is withheld by the primary packaging material—the glass cartridge and the sealed rubber septum. The friction force between the cartridge and rubber plunger is a function of the speed of travel and must be characterized for various injection speeds.
3. Testing Methodologies for Force and Dose Accuracy
3.1 ISO 11608-1 Testing Requirements
ISO 11608-1 specifies comprehensive testing procedures for dose accuracy and force characteristics. Key test categories include:
Dose Accuracy Tests: The injector must deliver precise and repeatable doses within allowable deviation limits. Testing must be conducted across different dose levels and environmental conditions. The standard specifies testing under:
- Standard atmosphere conditions
- Cool atmosphere conditions
- Warm atmosphere conditions
- After dry heat storage preconditioning
- After cold storage preconditioning
- Last-dose accuracy testing (for system designations A and C only)
Injection Force Tests: Measure the force required to initiate and maintain injection. Testing must verify that the force remains within acceptable limits across the device’s lifecycle.
Life-Cycle Testing: For reusable pens (system designations A and B), life-cycle testing with preconditioning is required to verify functional stability over the device’s intended lifespan.
3.2 Force Measurement Equipment
Accurate force measurement requires specialized testing equipment:
- Load cells of appropriate capacity (e.g., 5 N, 50 N, 500 N) are used to measure forces with precision
- Texture analyzers can measure injection force and force-distance profiles
- Torque meters measure dialing torque for dose setting
- Automated testing systems can measure actuation force, dosage accuracy, and plunger movement in one continuous process
The most important requirements when testing medical products are the reproducibility of results and the minimization of operator influences. Automated systems are increasingly used to meet these requirements.
The Instron Autoinjector Testing System, developed in partnership with pharmaceutical companies, measures a variety of essential performance requirements, including cap removal, dose accuracy, activation force, injection time, needle depth, and needle guard lockout.
3.3 Real-World Performance Data
Recent studies demonstrate the practical application of force and dose accuracy testing:
A functional evaluation of the reusable JuniorSTAR half-unit insulin pen tested 60 pens under standard atmospheric conditions with three different insulin types. The dose accuracy was tested according to ISO 11608-1:2012 at doses of 0.010, 0.155, and 0.300 ml. The mean injection force was 6.0 N, 4.3 N, and 5.1 N for the three insulin types respectively. The pen met all ISO criteria for dose accuracy.
The DuraTouch reusable insulin pen was tested for dosing accuracy, activation force, maximum dose-setting torque, hold force, and injection time across a range of insulin doses (1, 40, and 80 units) under various temperature and storage conditions. Dosing accuracy remained consistent across all conditions tested at each dose.
A study of disposable pens delivering pramlintide found mean dose accuracy of 96.04 to 102.45% (SD 0.3 to 1.4 µg) for the 60 µg pen and 98.16 to 101.83% for the 120 µg pen. Injection-force testing was conducted at multiple temperatures (18–28°C) and humidities (25–75%).
The Tempo Pen connected insulin pen system was tested for dose accuracy and reliability at three doses under standard atmospheric conditions. The system accurately delivered doses and reliably captured and stored insulin dosing information.
4. Material Selection and Its Impact on Force Calibration
4.1 Polymer Selection for Mechanical Components
The choice of materials directly affects force calibration and dose accuracy:
- POM and PBT are preferred for consistent actuation and torque control due to their dimensional stability and creep resistance
- Ultra-low-friction POM grades have been developed specifically for precision injection molding of medical device components
- Tribologically modified grades offer exceptional low friction and low wear, avoiding frictional force, abrasion, and squeaking during operation
4.2 Lubrication and Surface Engineering
Lubrication plays a critical role in force consistency:
- Uneven silicone oil application leads to unstable injection force
- Silicone-based internal lubricating additives significantly improve sliding performance
- The new ultra-low-friction Delrin grade is suitable for high-volume manufacture
4.3 Spring Materials
Spring performance depends on material selection and heat treatment:
- Wave springs offer space-saving design and precise force output
- Profiled-load springs deliver nearly constant force over the entire stroke
- Spring stiffness and travel must be carefully selected to ensure the drug is delivered at a controlled rate for accurate dosing
5. Environmental Factors and Dose Accuracy
5.1 Temperature Effects
Dose accuracy must be verified across a range of environmental conditions. ISO 11608-1 requires testing under cool, standard, and warm atmospheres. Studies have confirmed that pens meeting ISO standards maintain dose accuracy across temperature ranges.
5.2 Aging and Shelf Life
Dose accuracy must be maintained throughout the product’s shelf life. Testing after dry heat and cold storage preconditioning verifies that aging does not compromise performance. FDA requires dose accuracy testing after shipping and aging.
5.3 Humidity Effects
Testing at various humidities (25–75%) ensures that moisture does not affect friction characteristics or dose accuracy.
6. Practical Recommendations for Manufacturers
6.1 Design for Force Consistency
- Select materials with stable friction characteristics—POM and PBT are preferred for moving parts
- Control lubrication processes rigorously to ensure consistent application
- Design for tolerance management to minimize stack-up effects
- Validate spring performance across the full lifecycle
- Conduct tribological analysis early in the design phase
6.2 Testing and Validation
- Perform dose accuracy testing at all dose levels and environmental conditions per ISO 11608-1
- Measure injection force using calibrated load cells or texture analyzers
- Conduct life-cycle testing for reusable devices
- Document all test methods, validation, and results as part of the technical compliance file
- Include device functionality data in CTD Module 3.2.P.8.3 and 3.2.R to support regulatory approval
6.3 Quality Control in Manufacturing
- Perform incoming inspection of springs and other critical components
- Monitor lubrication consistency through process control
- Conduct in-process force testing to detect variations early
- Implement statistical process control for critical dimensions
7. Emerging Trends and Future Directions
7.1 Connected and Smart Pens
Connected insulin pen systems, such as the Tempo Pen with Tempo Smart Button, combine dose accuracy with digital data capture. These systems accurately deliver doses and reliably capture and store insulin dosing information, enhancing patient adherence and clinical monitoring.
7.2 High-Viscosity Biologics
The trend toward concentrated biologics and high-viscosity formulations places greater mechanical demands on pen injectors. These drugs require greater force to expel, necessitating stronger springs, more robust drive mechanisms, and optimized fluid paths.
7.3 Advanced Testing Systems
Next-generation testing systems, such as the Instron Autoinjector Testing System, offer full functionality testing of pens and autoinjectors to ISO 11608. These systems measure cap removal, dose accuracy, activation force, injection time, needle depth, and needle guard lockout in a single automated process.
Conclusion
Force calibration and dose accuracy are the twin pillars upon which the reliability of injection pens rests. From the selection of materials with stable friction characteristics to the rigorous testing protocols of ISO 11608-1, every aspect of pen injector design and manufacturing must be aligned toward the goal of consistent, precise drug delivery.
The regulatory landscape continues to evolve, with ISO 11608-1:2022 designating dose accuracy as a primary function, FDA treating pens as combination products requiring complete validation data, and USP <382> establishing functional proficiency requirements for elastomeric closures.
For pharmaceutical manufacturers and packaging partners, understanding the relationship between force calibration and dose accuracy is essential—not only for regulatory compliance but for ensuring patient safety, therapeutic efficacy, and commercial success.
At Vialab Pharmaceutical Packaging Co., Ltd. , we bring decades of expertise in pharmaceutical packaging and drug delivery components to support our partners in achieving the highest standards of dose accuracy and force calibration. From injection pens (disposable and reusable) and glass vials to sterile vials and aluminum caps, every component we manufacture is designed with ISO/GMP compliance and rigorous quality control at its core.
Whether you are developing a new pen injector, optimizing an existing mechanical design, or seeking to enhance your quality control processes, our team of packaging experts is ready to provide the technical guidance and manufacturing excellence you need to succeed in this rapidly evolving market.
Contact Vialab Pharmaceutical Packaging Co., Ltd. today to discuss your injection pen force calibration and dose accuracy requirements and discover how our precision pharmaceutical packaging solutions can support your next product launch.